Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02698475
Brief Title: An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age (CADMUS Jr)

First Submitted : February 29, 2016
First Submitted that Met QC Criteria : February 29, 2016
First Posted : March 3, 2016 (Estimate)

Results First Submitted : August 12, 2020
Results First Submitted that Met QC Criteria : August 12, 2020
Results First Posted : August 28, 2020

Certification/Extension First Submitted : December 20, 2018
Certification/Extension First Submitted that Met QC Criteria : December 20, 2018
Certification/Extension First Posted : December 27, 2018

Last Update Submitted that Met QC Criteria : October 27, 2020
Last Update Posted : November 18, 2020